40 companies had executives and directors buying in open-market trades in filings dated Jun 10, 2019, about $90.5 million combined. EVFM topped the list with roughly $30 million, led by PDL BIOPHARMA, INC..
C-suite buying: 13 companies. Cluster buying (3+ insiders) is running at 167 companies this month. As always, a purchase is a data point, not a recommendation.